|Avian–human influenza epidemic model|
S Iwami, Y Takeuchi, X Liu
Mathematical biosciences 207 (1), 1-25, 2007
|SVIR epidemic models with vaccination strategies|
X Liu, Y Takeuchi, S Iwami
Journal of Theoretical Biology 253 (1), 1-11, 2008
|Optimal control strategy for prevention of avian influenza pandemic|
E Jung, S Iwami, Y Takeuchi, TC Jo
Journal of theoretical biology 260 (2), 220-229, 2009
|Cell-to-cell infection by HIV contributes over half of virus infection|
S Iwami, JS Takeuchi, S Nakaoka, F Mammano, F Clavel, H Inaba, ...
Elife 4, e08150, 2015
|Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy|
M Horiike, S Iwami, M Kodama, A Sato, Y Watanabe, M Yasui, Y Ishida, ...
Virology 423 (2), 107-118, 2012
|Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization|
M Iwamoto, W Saso, R Sugiyama, K Ishii, M Ohki, S Nagamori, R Suzuki, ...
Proceedings of the National Academy of Sciences 116 (17), 8487-8492, 2019
|A heart–brain–kidney network controls adaptation to cardiac stress through tissue macrophage activation|
K Fujiu, M Shibata, Y Nakayama, F Ogata, S Matsumoto, K Noshita, ...
Nature medicine 23 (5), 611-622, 2017
|APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model|
K Sato, JS Takeuchi, N Misawa, T Izumi, T Kobayashi, Y Kimura, S Iwami, ...
PLoS pathogens 10 (10), e1004453, 2014
|Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells|
M Mahgoub, J Yasunaga, S Iwami, S Nakaoka, Y Koizumi, K Shimura, ...
Proceedings of the National Academy of Sciences 115 (6), E1269-E1278, 2018
|Avian flu pandemic: Can we prevent it?|
S Iwami, Y Takeuchi, X Liu
Journal of theoretical biology 257 (1), 181-190, 2009
|Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice|
K Sato, N Misawa, M Fukuhara, S Iwami, DS An, M Ito, Y Koyanagi
Journal of virology 86 (9), 5000-5013, 2012
|Multidrug treatment with nelfinavir and cepharanthine against COVID-19|
H Ohashi, K Watashi, W Saso, K Shionoya, S Iwanami, T Hirokawa, ...
|Prevention of avian influenza epidemic: What policy should we choose?|
S Iwami, Y Takeuchi, A Korobeinikov, X Liu
Journal of theoretical biology 252 (4), 732-741, 2008
|A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain|
Y Kakizoe, S Nakaoka, CAA Beauchemin, S Morita, H Mori, T Igarashi, ...
Scientific reports 5 (1), 1-14, 2015
|Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy|
S Iwami, Y Takeuchi, Y Miura, T Sasaki, T Kajiwara
Journal of theoretical biology 246 (4), 646-659, 2007
|Quantification of deaminase activity-dependent and-independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation|
T Kobayashi, Y Koizumi, JS Takeuchi, N Misawa, Y Kimura, S Morita, ...
Journal of virology 88 (10), 5881-5887, 2014
|HIV-1 Vpr Accelerates Viral Replication during Acute Infection by Exploitation of Proliferating CD4+ T Cells In Vivo|
K Sato, N Misawa, S Iwami, Y Satou, M Matsuoka, Y Ishizaka, M Ito, ...
PLoS pathogens 9 (12), e1003812, 2013
|Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection|
Y Koizumi, H Ohashi, S Nakajima, Y Tanaka, T Wakita, AS Perelson, ...
Proceedings of the National Academy of Sciences 114 (8), 1922-1927, 2017
|Immune impairment in HIV infection: Existence of risky and immunodeficiency thresholds|
S Iwami, T Miura, S Nakaoka, Y Takeuchi
Journal of Theoretical Biology 260 (4), 490-501, 2009
|Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model|
S Iwami, BP Holder, CAA Beauchemin, S Morita, T Tada, K Sato, ...
Retrovirology 9 (1), 1-12, 2012